Surgical Site Infections at a West Cameroon Hospital

Status Completed

Clinical Trial Summary

Surgical site infections (SSI) constitute an important health concern in low and middle income countries, leading to prolonged hospital stay and increased costs. Previous studies indicate that in Africa up to 1/3 of patients undergoing surgery may be affected by a postoperative infection. The development and implementation of context-specific SSI prevention guidelines is important to reduce this complication. To deploy efficient context-specific measures, data on epidemiology and microbiology of these infections are needed. This means to adapt the prevention measures to the context-specific risk factors for surgical site infections in resource-limited settings, and to give locally adapted recommendations on antimicrobial therapy based on local resistance patterns. However, data in this respect are scarce in low and middle income countries. This present study will contribute to the needed epidemiology and microbiology data on SSI in Cameroon. It will be carried out as a prospective cohort study at the Mbouo Protestant hospital in the West Region of Cameroon. The incidence, microbial spectrum and respective antimicrobial resistance of SSI as well as the risk factors of SSI will be systematically investigated. The study will include 300 patients at the Hôpital Protestant de Mbouo (HPM) who underwent surgery and gave their informed consent for inclusion, the timeframe is 04/2021 - 11/2021. An active SSI surveillance system will be put in place for 30 postoperative days to diagnose SSI. Expected outcomes: The incidence of SSI is likely to be higher than 10%. Concerning risk factors, preoperative bodywashing and perioperative antibioprophylaxis is expected to be protective against SSI. Up to 1/3 of SSI are expected to occur after hospital discharge. For the microbial spectrum, a high proportion of Staphylococcus aureus is likely to be found. For the antimicrobial resistance no estimation can be give as data is non-existent in that region from the literature.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05018884
Study type	Observational [Patient Registry]
Source	Universite Evangelique du Cameroun
Contact
Status	Completed
Phase
Start date	April 26, 2021
Completion date	February 4, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05529173` - Povidone-Iodine for Nasal Decolonization	Phase 4
Recruiting	`NCT03295955` - Comparing Efficacy of Postoperative Oral Antibiotic Use in Trans-Oral Thyroidectomy	N/A
Not yet recruiting	`NCT05276687` - Efficacy of Diluted Betadine vs Antibiotic Installation Before Surgical Wound Closure in Prevention of Post Cardiac Surgery Wound Infection	Phase 4
Completed	`NCT02776774` - Topical Antibiotic Treatment for Spine Surgical Site Infection
Terminated	`NCT00386477` - Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial	N/A
Not yet recruiting	`NCT03872544` - Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Recruiting	`NCT05077592` - Addition of Pre-wound Closure Povidone Iodine Wash Versus Direct Wound Closure Effect on Surgical Site Infections	Phase 4
Completed	`NCT03148067` - Incidence and Risk Factors for Surgical Site Infection After Intramedullary Nailing of Femoral and Tibial Fractures
Enrolling by invitation	`NCT03880188` - Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Completed	`NCT01890720` - Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section	N/A
Recruiting	`NCT06319235` - Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®	Phase 1/Phase 2
Completed	`NCT02919410` - Bacterial Colonization With and Without Iodophor-impregnated Adhesive Drapes in Hip Surgery: a Prospective, Randomized Trial	N/A
Completed	`NCT02020018` - Negative Pressure Wound Therapy for Prevention of Poststernotomy Infection	N/A
Completed	`NCT01741649` - Clorhexidine Versus Povidone for the Prevention of Surgical Site Infection After Cesarean Section	N/A
Completed	`NCT01340534` - Supplemental Perioperative Oxygen to Reduce the Incidence of Post-cesarean Wound Infection	Phase 3
Not yet recruiting	`NCT01457859` - Effectiveness of Triclosan Coated Sutures in Preventing Leg Wound Infection After Coronary Artery Bypass Surgery	Phase 4
Completed	`NCT03365219` - Alexis O-Ring Wound Retractor for the Prevention of Post-cesarean Surgical Site Infections	N/A
Completed	`NCT01026259` - Local Warming of Surgical Incisions	Phase 3
Completed	`NCT03574090` - Study the Efficacy of Topical Antibiotherapy in the Prophylaxis of Incisional Surgical Infection in Colorectal Surgery	Phase 4
Completed	`NCT03199911` - Topical Antibiotic Prophylaxis for Eyelids	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Surgical Site Infections at a West Cameroon Hospital — SSI Mbouo

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms